Ingredient or product comparison
The Unvarnished Truth About GHK-Cu vs TB-4
Here's the honest answer: neither peptide is 'better'. They address entirely different biological processes, and choosing based on general claims like 'tissue repair' will derail your research outcomes. GHK-Cu remodels extracellular matrix at the genetic trans
This source-based comparison does not add ratings or recommend a winner.
- Here's the honest answer: neither peptide is 'better'. They address entirely different biological processes, and choosing based on general claims like 'tissue repair' will derail your research outcomes. GHK-Cu remodels extracellular matrix at the genetic transcription level. It literally changes which collagen genes fibroblasts express. TB-4 modulates immune response and cell migration. It changes how quickly inflammatory cells arrive and how much scarring forms afterward. If your protocol measures collagen density, elastin synthesis, or dermal thickness, TB-4 will not deliver the endpoint you need. If you're measuring angiogenesis, immune infiltration, or post-ischemic recovery, GHK-Cu won't replicate TB-4's efficacy. The mechanism matters more than the marketing.
- GHK-Cu works best in aged tissue models because it resets fibroblast gene expression to a younger phenotype. This is not speculation, it's demonstrated in microarray studies showing 4,000+ gene changes after GHK-Cu exposure. TB-4 works best in acute injury models because it reduces the inflammatory cascade that leads to fibrosis and scarring. The earlier you administer it post-injury, the more dramatic the effect. Our team has reviewed this across hundreds of comparative protocols. The pattern is consistent every time: peptide selection aligned with tissue type and measured endpoint determines reproducibility. Choose based on mechanism, not popularity.